Tarrant County Engages Avèro Advisors to Lead ERP Landscape Assessment and Strategic Roadmapping
Tarrant County awarded Avèro the contract following a competitive procurement process. The initiative centers on a detailed needs assessment and strategic analysis of business functions across County departments. The findings will guide leadership in identifying improvement opportunities and establishing a clear, actionable roadmap—whether that involves optimizing the existing system or pursuing other enhancements.
"Good decisions begin with a clear understanding of where you are," said Abhijit Verekar, CEO of Avèro Advisors. "Tarrant County is taking a thoughtful, data-driven approach to evaluating its ERP environment. Our role is to provide the expert guidance they need to uncover the right path forward—with clarity, confidence, and a commitment to their long-term success."
Key Objectives of the Engagement:
ERP Environment Assessment: Review of the County's current ERP ecosystem, including technology, user experience, and functional alignment across departments.Operational Workflow Analysis: Detailed documentation and evaluation of core business functions to uncover pain points, duplication, and modernization opportunities.Strategic Roadmap Development: Creation of a future-oriented plan that aligns technology investments with operational priorities—tailored to County goals.Optional Support for Future Procurement: Advisory services may extend to vendor evaluation and implementation support should the County choose to pursue changes.
This engagement reflects Tarrant County's commitment to proactive governance, fiscal responsibility, and continuous improvement through technology and process alignment.
About Avèro AdvisorsAvèro Advisors is a premier independent consulting firm guiding public sector organizations through complex digital transformations. With a focus on ERP modernization, process improvement, and operational strategy, Avèro equips governments with the tools and insights needed to thrive in a rapidly evolving landscape.
About Tarrant CountyLocated in North Texas, Tarrant County serves a population of over two million residents and is one of the fastest-growing and most diverse counties in the nation. The County is dedicated to efficient, transparent service delivery and strategic investment in modern infrastructure.
Media Contact:Abhijit VerekarCEO/FounderAvèro Advisors av@averoadvisors.comaveroadvisors.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/tarrant-county-engages-avero-advisors-to-lead-erp-landscape-assessment-and-strategic-roadmapping-302464535.html
SOURCE Avero Advisors
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 minutes ago
- Yahoo
Checkpoint Systems expands its RFID capabilities with a new facility in Mexico City
PHILADELPHIA, July 8, 2025 /PRNewswire/ -- Checkpoint Systems, a global leader in RFID technology and solutions, is proud to announce the opening of its new manufacturing facility in Mexico City. This strategic expansion underscores Checkpoint's commitment to meeting the rapidly growing demand for RFID solutions in the North American region whilst increasing its global scale and capacity. A strategic location to meet growing demandLocated in the heart of Mexico, this facility places Checkpoint Systems closer to its customers, enabling faster response times and streamlined supply chain operations. With the RFID market experiencing unprecedent growth across North America and the globe, the new factory is ideally positioned to support retail and industry with the high-quality inlays they need to succeed in an increasingly connected world. Ben Lilienthal, President Checkpoint Systems Worldwide, says: "Our investment in this facility reflects our dedication to innovation, operational excellence, and providing unmatched value to our customers. By establishing a presence in Mexico, we are reinforcing our ability to deliver cutting-edge RFID solutions faster and more efficiently than even before." World-class capabilitiesThe 10,000 square meters facility is equipped with the latest manufacturing technologies, ensuring the production of top-quality RFID inlays. Featuring advanced bonding, converting and personalization machines, the factory specializes in manufacturing blank, printed and encoded inlays, supporting an annual production capacity of 4.2 billion inlays. Additionally, the facility meets stringent certification standards, including SMETA and FSC CoC, ensuring high-quality production and operational excellence. Beyond inlay production, the site also boasts full printing and converting capabilities, allowing RFID products to be adapted for a wide range of industries, label formats and form factors. This comprehensive approach to manufacturing makes Checkpoint Systems one of the very few RFID providers in the world to offer such an integrated solution under one roof. In regards to this, Christian Haider, Director of Plant Operations, adds: "This new facility is a testament to our commitment to advanced manufacturing and quality production. With state-of-the-art technology and a highly skilled workforce, we are well-positioned to meet the increasing demand for RFID inlays and deliver superior products to our customers." Unmatched RFID FootprintWith the strength of more than 200 CCL plants worldwide, Checkpoint Systems offers an extensive and unparalelled RFID production network. This global footprint ensures customers benefit from a truly scalable, reliable and agile supply chain, uniquely positioning Checkpoint to support growing demand across industries. Significant investment and Job CreationThe new facility represents an investment of 40 million USD and demonstrates Checkpoint Systems' confidence in the North American market. This initiative is expected to create 100 job opportunities in the region, contributing to the local economy and fostering community growth. About Checkpoint Systems, Inc. Checkpoint Systems, a division of CCL Industries, is a global leader in RFID/RF-driven loss prevention, inventory control & traceability, branding, supply chain management and business data intelligence solutions. Its +50 years' expertise are behind its unique combination of cloud-based SaaS, connected hardware, labels and tags offering intelligent solutions that bring clarity and efficiency to companies, from source to shop. Checkpoint's range of technological solutions offers retailers and brands - from several markets such as food & beverage, apparel & footwear, general merchandise, health & beauty, supply chain & logistics -among others- a connected approach to profitability and more seamless and engaging shopper experiences. To find out more go to About CCL Industries CCL Industries Inc., a world leader in specialty label and packaging solutions for global corporations, small businesses, and consumers, employs over 25,700 people and operates over 213 production facilities in 43 countries, with corporate offices in Toronto (Canada) and Framingham (Massachusetts). For more information, visit LinkedInYouTubeTwitter View original content to download multimedia: SOURCE Checkpoint Systems, Inc. Sign in to access your portfolio
Yahoo
32 minutes ago
- Yahoo
RS PRO facilitates food and beverage manufacturing
RS PRO offers an extensive portfolio of products fundamental for integrating and operating smart solutions and ensuring the safety, efficiency, compliance, and profitability of food and beverage production processes. FORT WORTH, Texas, July 8, 2025 /PRNewswire/ -- RS, a high-service global product and service solutions provider for industrial customers, offers an extensive portfolio of RS PRO brand products essential for the food and beverage manufacturing industry. The global food and beverage industry was valued at $6.96 trillion in 2024, and it's projected to grow at a CAGR of 6.2%, achieving a value of $9.4 trillion by the end of 2029. But — despite its massive size and steady growth — stringent regulations, complex supply chains, and rising costs make the food and beverage industry an especially challenging one to succeed in. To remain competitive, many food and beverage manufacturers are turning to strategic solutions. As such, much of this projected growth will be driven by the increased adoption of industrial automation, digitization, AI, and blockchain technologies aimed at improving safety, efficiency, traceability, sustainability, and profitability. The RS PRO portfolio of products for the food and beverage manufacturing industry offers more than 27,800 solutions that — like all RS PRO products — are meticulously designed to provide an unbeatable combination of quality, choice, and value and backed by the RS PRO Seal of Approval, which is only awarded after a rigorous testing, inspection, and auditing process based on demanding international standards. Solutions include more than: 10,100 fasteners that facilitate the assembly of complex industrial machinery, equipment, and structures, provide structural integrity, load distribution, and vibration resistance, and expedite maintenance and repairs. 5,200 tools and tool kits, including files, rasps, chisels, saws, abrasives, air tools, balancers, and cutters. 7,300 connectivity products essential to the reliable transmission of power, signal, and data between devices and systems, ranging from terminals, lugs, and ferrules to hook-up wire, Ethernet cables, and RF cable assemblies and a multitude of accessories, including cable ties, clamps, clips, and strain reliefs, conduit fittings, and wire ducts, raceways, and trays. 1,500 switches, ranging from electrical switches that create or break electrical connections to allow or prevent the flow of current or data — including pushbutton switches, limit switches, float switches, disconnect switches, and emergency stop switches — to networking switches, like Ethernet switches, that connect multiple devices within a local area network (LAN). 900 sensors, including photoelectric sensors that use a beam of light to detect the presence or absence of objects or changes in their surface conditions, proximity sensors that detect the presence of objects within a certain range by sensing changes in magnetic or capacitive fields or ultrasonic waves, and pressure sensors that measure and convert pressure into an electrical signal. 1,800 enclosures that provide critical protection for the various electronic components that comprise industrial control systems and reliably withstand the hazards of food and beverage manufacturing environments, including high-pressure and -temperature washdowns, bacteria, chemicals, and corrosion. 670 light bulbs representing LED, halogen, incandescent, and heat lamp technologies and used for ambient lighting, machine lighting, drying, sterilization, and cooking processes, and maintaining food-safe temperatures throughout production. And while not all smart solutions themselves, these products are all fundamental for integrating and operating smart solutions, like automation and digitization technologies, and ensuring the safety, efficiency, compliance, and profitability of food and beverage production processes. "Our portfolio of RS PRO products for the food and beverage manufacturing industry provides customers with a single source for industrial-grade solutions that are rigorously tested and field-proven to deliver high-quality performance in a wide range of industrial applications and environments," said Sonya May, RS PRO Manager. "It also offers a varied selection designed to satisfy diverse needs and comparable savings you can take to the bank. In addition, most RS PRO products — including all tools and appliances — are covered by a three-year warranty. This unique value proposition has earned us the business of more than half a million industrial customers and counting, as well as an astonishingly low return rate of less than 0.02%." The RS PRO portfolio is designed to satisfy the needs of virtually every industrial application and working environment and provide competitive savings compared to branded alternatives without compromising performance, allowing customers of all sizes to work confidently. It features more than 90,000 products across 1,500 technologies, including more than 17,000 in-stock and ready-to-ship solutions and a growing selection of sustainable solutions. These field-proven, industrial-grade products can also be combined into integrated solutions to further simplify customers' sourcing and purchasing processes and save even more time and money. For more information about RS PRO products that facilitate food and beverage manufacturing processes and help manufacturers overcome challenges including stringent regulations, complex supply chains, and rising costs, please visit the links embedded here. For assistance overcoming these and other common food and beverage industry challenges or identifying, procuring, installing, and maintaining RS PRO products for food and beverage manufacturing — including fasteners, tools, connectivity solutions, switches, sensors, enclosures, and lighting — please contact your local RS representative at 1.866.433.5722 or reach out to our technical support team. RS can help you reduce costs while improving quality, strengthen your supply chain resilience and mitigate disruptions, leverage data analytics to improve decision-making and identify optimization opportunities, and source trusted solutions from leading industrial suppliers to support your business goals. To learn more about how RS supports the food and beverage manufacturing industry, check out its food and beverage manufacturing and process manufacturing industry pages, and relevant selections from the RS Expert Advice series, including: "Digital transformation and integration in process manufacturing: Part I" and "Part II" "Food and beverage industry tracking and tracing" "Seven key products for improving food and beverage manufacturing processes" "Six solutions for evolving safety and compliance challenges in the food and beverage industry" About RSRS is a high-service global product and service solutions provider for industrial customers, enabling them to operate efficiently and sustainably. We operate in 36 markets, stock over 830,000 industrial and specialist products, and list an additional five million relevant for our industrial customers, sourced from over 2,500 suppliers. This extensive range supports our customers across the industrial lifecycle of designing, building, and maintaining equipment and operations. We enhance their experience through a tailored service model, leveraging our efficient physical, digital, and process infrastructure sustainably. We combine a technically led and digitally enabled approach with an exceptional team of experts; ultimately, it's our people that make the difference. Our purpose, making amazing happen for a better world, reflects our focus on delivering results for people, planet, and profit. RS Group plc is listed on the London Stock Exchange with stock ticker RS1 and in the year ended 31 March 2025 reported revenue of £2,904 million. For more information, please visit or connect with us on LinkedIn or X (Twitter). About RS in the AmericasIn the Americas region, RS stocks more than 250,000 industrial and electronic products from more than 700 trusted suppliers. These solutions cover categories extending from automation and control equipment to interconnect, passive, active, and electromechanical components and include more than 90,000 high-quality, competitively priced RS PRO products. For more information, please visit or connect with us via social media on Facebook, X (Twitter), LinkedIn, and YouTube. Image Download:RS PRO Food & Bev Manufacturing Editorial Contact & Media Inquiries:Erica Goode, RS Director of Marketing – U.S. and View original content to download multimedia: SOURCE RS Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Colorectal Cancer Treatment Market Size is Projected to Reach USD 24.77 Billion, with a Robust 3.2% CAGR till 2031, Rising Prevalence of Cancer Boosts
NEW YORK, July 8, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global colorectal cancer treatment market is observing significant growth owing to the increasing prevalence of cancer and growing demand for rare disease diagnostic tools. The colorectal cancer treatment market is expected to reach US$24.77 billion by 2031 from US$19.93 billion in 2024, at a CAGR of 3.2% during the forecast period. Colorectal cancer, also referred to as colon cancer or bowel cancer, develops in the colon or rectum. The disease is a significant health concern, being the third most common cancer worldwide. The report runs an in-depth analysis of market trends, key players, and future opportunities. The colorectal cancer treatment market comprises a vast array of products and services that are expected to register strength during the forecast period. To explore the valuable insights in the Colorectal Cancer Treatment Market report, you can easily download a sample PDF of the report – Overview of Report Findings Increasing Burden of Colorectal Cancer: According to the World Health Organization (WHO), colon cancer is the second leading cause of cancer-related deaths worldwide. In 2022, there were over 1.9 million new colorectal cancer cases and more than 930,000 deaths due to this disease globally. Incidence rates were highest in Europe, as well as Australia and New Zealand, while mortality rates were highest in Eastern Europe. By 2040, the burden of colorectal cancer is projected to increase to 3.2 million new cases per year—a 63% rise—and to 1.6 million deaths per year, reflecting a 73% increase. The increasing prevalence of colorectal cancer is expected to drive the demand for its treatment in the coming years. Surging Advancements in Treatments and Product Approvals: The advancement and acceptance of sophisticated treatments; such as targeted therapies (e.g., cetuximab, bevacizumab, regorafenib), immunotherapies, and combination therapies; have enhanced patient outcomes and broadened treatment options. Continued research and new product approvals, including biosimilars and personalized medicine, are driving market growth. For instance, in April 2025, the Food and Drug Administration (FDA) approved the combination of two immunotherapy drugs, nivolumab (Opdivo) and ipilimumab (Yervoy), for the initial treatment of some patients with advanced colorectal cancer. This approval expands the use of this immunotherapy combination into the first-line setting and can be used as the initial treatment. Geographical Insights: In 2024, North America led the market with a substantial revenue share, followed by Europe and APAC. Asia Pacific is expected to register the highest CAGR during the forecast period. For Detailed Colorectal Cancer Treatment Market Insights, Visit: Market Segmentation Based on treatment type, the colorectal cancer treatment market is segmented into surgery, chemotherapy, targeted therapy, immunotherapy, and others. In 2024, the surgery segment held the largest colorectal cancer treatment market share and is expected to register the highest CAGR during 2025–2030. By age group, the colorectal cancer treatment market is segmented into below 49 years, 50–64 years, and above 65 years. The above 65 years segment held the largest colorectal cancer treatment market share in 2024. In terms of application, the colorectal cancer treatment market is divided into preclinical drug development, biomarker analysis, translating research, and biobanking. The preclinical drug development segment held the largest share of the colorectal cancer treatment market in 2024. In terms of end user, the colorectal cancer treatment market is segmented into hospitals, specialty clinics, home care, and others. The hospitals segment held the largest share of the colorectal cancer treatment market in 2024. The colorectal cancer treatment market is segmented into five major regions: North America, Europe, APAC, Middle East and Africa, and South and Central America. Stay Updated on The Latest Colorectal Cancer Treatment Market Trends: Competitive Strategy and Development Key Players: A few major companies operating in the colorectal cancer treatment market are Champions Oncology, Inc.; Charles River Laboratories, Inc.; Crown Bioscience, Inc.; EPO Berlin-Buch GmbH; Hera BioLabs; Horizon Discovery Group plc; Oncodesign; Pharmatest Services Ltd; Urolead; and Xentech. Trending Topics: Advanced Colorectal Cancer Treatments, AI in Colorectal Cancer Treatments, Oncology PDX models, and PDX models for research, among others. Global Headlines on Colorectal Cancer Treatment Takeda Pharmaceutical announced the approval for its oral targeted therapy FRUZAQLA (fruquintinib) from the US Food and Drug Administration (FDA) to treat adults having metastatic colorectal cancer (mCRC). FRUZAQLA is the first and only selective inhibitor of all three VEGF receptor kinases approved in the US for treating mCRC previously, regardless of biomarker status. Taiho Pharmaceutical Co., Ltd. announced that the US FDA had approved LONSURF (trifluridine/tipiracil) as a single agent and in combination with bevacizumab for treating mCRC patients. These patients are previously treated with oxaliplatin-, fluoropyrimidine-, and irinotecan-based chemotherapy, an anti-VEGF biological therapy. The Food and Drug Administration granted accelerated approval to adagrasib (Krazati) plus cetuximab developed by Mirati Therapeutics, Inc. for adults with KRAS G12C-mutated locally advanced or metastatic colorectal cancer (CRC), as determined by an FDA-approved test, who received prior treatment with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy. Purchase Premium Copy of Global Colorectal Cancer Treatment Market Size and Growth Report (2021-2031) at: The rising prevalence of colorectal cancer and increasing innovations in cancer therapies drive the colorectal cancer treatment market growth. Colorectal cancer continues to be one of the leading causes of illness and death worldwide, with millions of new cases diagnosed each year. The increasing prevalence of CRC directly correlates with an increased demand for a wide range of treatments such as surgery, chemotherapy, targeted therapies, immunotherapy, and supportive care services. Pharmaceutical and biotech firms are investing significantly in research and development to meet unmet needs, especially for younger patients and those suffering from advanced or resistant diseases. In November 2023, Takeda received the U.S. Food and Drug Administration (FDA) approval for FRUZAQLA (fruquintinib), an oral targeted therapy for adults with metastatic colorectal cancer (mCRC) who have been previously treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy. Additionally, the rise in early-onset cases is encouraging advancements in personalized medicine and less invasive surgical methods. According to an article published in White Rose in December 2024, in England, the use of minimally invasive surgery (MIS) for resections has significantly increased. For colon cancer, the percentage of resections performed using MIS increased from 34.9% in 2007 to 72.9% in 2021, while for rectal cancer it grew from 28.8% to 72.5%. Additionally, robot-assisted surgery for colon cancer increased from 0.1% in 2007 to 2.7% in 2021, and for rectal cancer from 0.2% in 2007 to 7.9% in 2021. However, there was a wide variation in the adoption of MIS at the hospital level between during 2007–2021. The report from The Insight Partners, therefore, provides several stakeholders—including PDX model developers, academic and research organizations, healthcare facilities, and others, with valuable insights to successfully navigate this evolving market landscape and unlock new opportunities. Trending Related Reports: The Kidney Cancer Therapeutics and Diagnostics Market is expected to register a CAGR of 4.9% from 2025 to 2031, The Cervical Cancer Diagnostics and Therapeutics Market is expected to register a CAGR of 4.5% from 2025 to 2031, The Ovarian Cancer Diagnostics and Therapeutics Market is expected to register a CAGR of 9.4% from 2025 to 2031 The Cancer Stem Cells Market is expected to register a CAGR of 19% from 2025 to 2031 The Cancer Therapy Market is expected to register a CAGR of 8.2% from 2025 to 2031 The Cancer Biopsies Market is expected to register a CAGR of 11.6% from 2025 to 2031 The Uterine Cancer Therapeutics & Diagnostics Market is expected to register a CAGR of 5.9% from 2025 to 2031 The Thyroid Cancer Diagnostics Market is expected to register a CAGR of 5.5% from 2025 to 2031 The Skin Cancer Diagnostics and Therapeutics Market is expected to register a CAGR of 5.6% from 2025 to 2031 The liver cancer diagnostics market size is projected to reach US$ 20.57 billion by 2031 The Pancreatic Cancer Therapy Market size is expected to reach US$ 6.47 billion by 2031 About Us: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact Us: If you have any queries about this report or if you would like further information, please contact us: Contact Person: Ankit MathurE-mail: +1-646-491-9876Home - Logo: View original content: SOURCE The Insight Partners Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
